/
Oncology
Follicular Lymphoma (FL)
10
Pipeline Programs↗
5
Active Trials↗
8
Companies Involved↗
Follicular Lymphoma (FL) is an early-stage landscape with 10 programs across 8 companies. 10 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 310
Approved
No programs
Analysis
Modality Breakdown
70%
Small molecule
7 of 10 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 10 classified programs, each share of the total. Modality classified for 100% of 10 pipeline programs.
Analysis
Trial Status
5
clinical trials
Recruiting2 · 40%
Active, not recruiting2 · 40%
Not yet recruiting1 · 20%
Clinical Trials
Trial Activity
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)